J. Bradwejn et D. Koszycki, IMIPRAMINE ANTAGONISM OF THE PANICOGENIC EFFECTS OF CHOLECYSTOKININ TETRAPEPTIDE IN PANIC DISORDER PATIENTS, The American journal of psychiatry, 151(2), 1994, pp. 261-263
Eleven panic disorder patients who panicked in response to exogenous c
holecystokinin tetrapeptide (CCK-4) were rechallenged after chronic tr
eatment with imipramine. In the rechallenge the patients displayed a m
arked reduction in the number and intensity of panic symptoms, duratio
n of symptoms, frequency of panic attacks, and cardiovascular responsi
veness. This study demonstrates that imipramine can antagonize the pan
icogenic effects of CCK-4.